Uncategorized
Ocular Therapeutix™ to Participate in Three Conferences in November 2015
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix™, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Amar Sawhney, Ph.D., President and Chief Executive Officer, will participate in three upcoming conferences in November including: Citi 2015 Global Healthcare 1x1 ConferenceWednesday, November 4, 2015The New York Palace Hotel, New York, NY Ophthalmology Innovation
